Hap Trading, LLC Hepion Pharmaceuticals, Inc. Call Options Transaction History

Hap Trading, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$0.57 - $1.22 $8,664 - $18,544	-15,200 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$0.93 - $1.29 $14,136 - $19,608	15,200 New	15,200 $1,000
Q4 2021 Feb 14, 2022	SELL	$1.14 - $1.58 $29,183 - $40,448	-25,600 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$1.39 - $2.1 $1,390 - $2,100	1,000 Added 4.07%	25,600 $5,000
Q2 2021 Aug 11, 2021	SELL	$1.56 - $2.26 $37,128 - $53,787	-23,800 Reduced 49.17%	24,600 $11,000
Q1 2021 May 14, 2021	BUY	$1.77 - $2.98 $44,073 - $74,202	24,900 Added 105.96%	48,400 $19,000
Q4 2020 Feb 16, 2021	BUY	$1.58 - $3.64 $37,130 - $85,540	23,500 New	23,500 $11,000

Ticker HEPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,229,600
Market Cap $51.8M
Description
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.